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Abstract: After human coronaviruses OC43, 229E and NL63, human coronavirus HKU1 
(HCoV-HKU1) is the fourth human coronavirus discovered. HCoV-HKU1 is a group 2a 
coronavirus that is still not cultivable. The G + C contents of HCoV-HKU1 genomes are 
32%, the lowest among all known coronaviruses with complete genome sequences 
available. Among all coronaviruses, HCoV-HKU1 shows the most extreme codon usage 
bias, attributed most importantly to severe cytosine deamination. All HCoV-HKU1 
genomes contain unique tandem copies of a 30-base acidic tandem repeat of unknown 
function at the N-terminus of nsp3 inside the acidic domain upstream of papain-like 
protease 1. Three genotypes, A, B and C, of HCoV-HKU1 and homologous recombination 
among their genomes, are observed. The incidence of HCoV-HKU1 infections is the 
highest in winter. Similar to other human coronaviruses, HCoV-HKU1 infections have 
been reported globally, with a median (range) incidence of 0.9 (0 – 4.4) %. HCoV-HKU1 
is associated with both upper and lower respiratory tract infections that are mostly self-
limiting. The most common method for diagnosing HCoV-HKU1 infection is RT-PCR or 
real-time RT-PCR using RNA extracted from respiratory tract samples such as 
nasopharyngeal aspirates (NPA). Both the pol and nucleocapsid genes have been used as 
the targets for amplification. Monoclonal antibodies have been generated for direct antigen 
detection in NPA. For antibody detection, Escherichia coli BL21 and baculovirus-
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expressed recombinant nucleocapsid of HCoV-HKU1 have been used for IgG and IgM 
detection in sera of patients and normal individuals, using Western blot and enzyme-linked 
immunoassay. 
Keywords: coronavirus; human; HKU1; novel 
 
1. Introduction 
Coronaviruses are positive-sense, single-stranded RNA viruses found in humans and a wide variety 
of animals. In humans, coronaviruses are mainly causes of respiratory tract infections, whereas in 
animals, they can cause respiratory, enteric, hepatic and neurological diseases of varying severity. As 
in other RNA viruses, the infidelity of RNA-dependent RNA polymerase results in high mutation rates. 
In addition, coronaviruses possess a unique mechanism of viral replication that leads to high 
frequencies of recombination, as well as the largest genome size (26.4 to 31.7 kb) among all known 
RNA viruses that gives this family of viruses extra plasticity [18,22,43]. All these factors have allowed 
the coronaviruses to adapt to new hosts and ecological niches. Traditionally, coronaviruses were 
classified into groups 1, 2 and 3, with groups 1 and 2 consisting of mammalian coronaviruses and 
group 3 being avian coronaviruses [2,22,47]. In 2008, the Coronavirus Study Group of the 
International Committee for Taxonomy of Viruses proposed three genera, Alphacoronavirus, 
Betacoronavirus and Gamma-coronavirus, to replace these three traditional groups of coronaviruses 
(http://talk.ictvonline.org/cfs-filesystemfile.ashx/__key/CommunityServer.Components.PostAttach-
ments/00.00.00.06.26/ 2008.085_ 2D00_122V.01.Coronaviridae.pdf). 
The SARS epidemic that originated from southern China in 2003 has boosted interest in all areas of 
coronavirus research, most notably, coronavirus biodiversity and genomics. Before 2003, there were 
only 10 coronaviruses with complete genomes available, including only two human coronaviruses, 
human coronavirus 229E (HCoV-229E) and human coronavirus OC43 (HCoV-OC43). These two 
human coronaviruses were discovered in the 1960s, with HCoV-229E being a group 1 coronavirus and 
HCoV-OC43 a group 2 coronavirus [17, 34]. After the SARS epidemic, up to December 2008, 16 
novel coronaviruses were discovered and their complete genomes sequenced. Among these 16 
previously unrecognized coronaviruses were two more human coronaviruses, human coronavirus 
NL63 (HCoV-NL63) and human coronavirus HKU1 (HCoV-HKU1) [37,39], ten other mammalian 
coronaviruses and four avian coronaviruses [7,16,23,24,27,28,33,40,41,44,46]. HCoV-NL63 is a   
group 1 coronavirus whereas HCoV-HKU1 is a group 2 coronavirus. In just a few years after their 
discoveries, numerous reports throughout the world had described the presence of HCoV-NL63 and 
HCoV-HKU1 in patients with respiratory infections in their corresponding countries. In this article, we 
reviewed our current understanding of the classification, virology, epidemiology, clinical diseases, 
laboratory diagnosis, treatment and prevention of HCoV-HKU1. 
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2. Classification and virology 
In the current system of classification in which group 2 coronaviruses are classified into group 2a, 
group 2b and the recently proposed groups 2c and 2d, HCoV-HKU1 is a group 2a coronavirus. 
Phylogenetically, no close relative with less than 10% nucleotide difference in any of the genes is 
present (Figure 1).  
Figure 1. Phylogenetic analysis of RNA-dependent RNA polymerases of coronaviruses 
with complete genome sequences available by the end of 2008. The tree was constructed 
by neighbor joining method using Kimura's two-parameter correction and bootstrap values 
calculated from 1000 trees. Nine hundred and fifty eight amino acid positions were 
included in the analysis. The scale bar indicates the estimated number of substitutions per 
50 amino acids.  
 
HCoV-229E, human coronavirus 229E (NC_002645); PEDV, porcine epidemic diarrhea virus 
(NC_003436); TGEV, porcine transmissible gastroenteritis virus (NC_002306); FCoV, feline 
coronavirus (AY994055); PRCV, porcine respiratory coronavirus (DQ811787); HCoV-NL63, 
human coronavirus NL63 (NC_005831); bat-CoV-HKU2 (EF203064), HKU4 (NC_009019), 
HKU5 (NC_009020), HKU8 (NC_010438), HKU9 (NC_009021), 1A (NC_010437), 1B 
(NC_010436), 512/2005 (NC_009657); HCoV-HKU1, human coronavirus HKU1 (NC_006577), 
HCoV-OC43, human coronavirus OC43 (NC_005147); MHV, mouse hepatitis virus (NC_006852); 
BCoV, bovine coronavirus (NC_003045); PHEV, porcine hemagglutinating encephalomyelitis 
virus (NC_007732); ECoV, equine coronavirus (NC_010327); SARS-CoV, SARS coronavirus 
(NC_004718); bat-SARS-CoV-HKU3, bat-SARS coronavirus HKU3 (NC_009694); IBV, 
infectious bronchitis virus (NC_001451); TCoV, turkey coronavirus (NC_010800); SW1, beluga 
whale coronavirus (NC_010646); BuCoV-HKU11, Bulbul coronavirus HKU11 (NC_011548); 
ThCoV-HKU12, Thrush coronavirus HKU12 (NC_011549); MuCoV-HKU13, Munia coronavirus 
HKU13 (NC_011550). 
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At the moment, 22 HCoV-HKU1 genomes have been sequenced [43]. The sizes of the genomes of 
HCoV-HKU1 range from 29,295 to 30,097 nucleotides. The G + C contents of HCoV-HKU1 genomes 
are 32%, the lowest among all known coronaviruses with complete genome sequences available. The 
genome organization of HCoV-HKU1 is similar to that of other coronaviruses, with the characteristic 
gene order 5’-replicase ORF1ab, spike (S), envelope (E), membrane (M), nucleocapsid (N)-3’ (Figure 
2). Additional genomic features of HCoV-HKU1 that are similar to all other group 2a coronaviruses 
include a putative transcription regulatory sequence (TRS) of CUAAAC, two papain-like protease 
domains (PL1
pro and PL2
pro) in nsp3 of ORF1ab, a haemagglutinin esterase (HE) gene between 
ORF1ab and S, and an internal ribosomal entry site upstream to the initiation codon of E [39]. Among 
all coronaviruses with complete genomes available, HCoV-HKU1 shows the most extreme codon 
usage bias, attributed most importantly to severe cytosine deamination that has led to C → U   
changes [45]. 
 
Figure 2. Genome organization of HCoV-HKU1. Predicted ORF 1ab, encoding the 
nonstructural polyproteins (nsp1 to nsp16) and ORFs encoding the HE, S, E, M and N 
structural proteins are indicated. Arrows indicate putative cleavage sites (with the 
corresponding nucleotide positions) of the replicase polyprotein encoded by ORF 1ab 
(amino acids at boundaries also shown) and S protein. Putative positions of TRS are 
marked by ▀. Major parts of ORF 1ab (PL1
pro, PL2
pro, 3CL
pro, pol and helicase) encoding 
key enzymatic activities are colored in yellow. ATR represents the acidic tandem repeat in 
nsp3. 
 
 
The ORF1ab replicase polyprotein is putatively cleaved by its papain-like proteases and 3C-like 
protease (3CL
pro) into 16 nonstructural proteins (nsp1 to nsp16) homologous to the corresponding ones 
in other coronaviruses. Analysis of the putative cleavage sites of the 3CL
pro revealed a unique putative Viruses 2009, 1                                       
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cleavage site at the junction between nsp13 and nsp14, which was also recognized in HCoV-NL63 
[38]. In addition to this unique putative cleavage site, all HCoV-HKU1 genomes contain tandem 
copies of a 30-base acidic tandem repeat (ATR) (variable numbers of perfect repeats of 
NDDEDVVTGD in the amino acid sequence followed by variable numbers of imperfect repeats) at the 
N-terminus of nsp3 inside the acidic domain upstream of PL1
pro [43]. This phenomenon was also 
observed in the two strains of HCoV-HKU1 found in France with this region of the genome 
characterized [35]. Although the function of the ATR is not known, these tandem copies of ATR have 
made the nsp3 of HCoV-HKU1 the longest nsp3 among all coronaviruses with complete genomes 
available.  
At least three genotypes, genotype A, B and C, of HCoV-HKU1, with inter-genotypic homologous 
recombination, have been observed. When the pol, S and N genes of clinical strains HCoV-HKU1 
were analyzed, it was observed that the strains fell into two clusters, designated genotypes A and B 
[25,42]. Interestingly, there were a few strains in which the sequences of pol genes were clustered with 
genotype A but those of S and N genes were clustered with genotype B [25,42]. Subsequent 
sequencing and analysis of 22 complete HCoV-HKU1 genomes found that there were three genotypes 
of HCoV-HKU1 and significant numbers of homologous recombination events have occurred among 
the three genotypes [43]. The most notable example was in a stretch of 29 bases at the 3’ end of nsp16, 
in which recombination between genotype A and genotype B has led to the generation of genotype C 
[43]. This represented the first example of homologous recombination in human coronavirus, and was 
also the first study to describe a distribution of natural recombination spots in the entire genome of 
field isolates of a coronavirus [43]. Although no complete genome sequence is available for HCoV-
HKU1 strains found outside Hong Kong, sequences of fragments of pol, S and N of the strains 
suggested that all three genotypes are probably distributed globally. Analysis of a single gene is not 
sufficient for genotyping of HCoV-HKU1, but would require sequencing of at least two gene loci, one 
from nsp10 to nsp16, such as pol or helicase, and another from HE to N, such as S or N. 
Although HCoV-HKU1 is still not cultivable using a wide variety of cell lines, neuron-glia culture 
and intracerebral inoculation of suckling mice, the biogenesis, subcellular localization and intracellular 
trafficking of S in HCoV-HKU1 as well as its interaction with major histocompatibility complex class 
I C molecule (HLA-C) were characterized recently [4, 6]. Results of these studies confirmed that S of 
HCoV-HKU1 was N-glycosylated in the endoplasmic reticulum (ER) with high-mannose N-glycans, 
and it was first distributed in the ER and Golgi, subsequently also detected in vesicles throughout the 
cytoplasm, and finally on the cell surface. Cleavage of S into S1 (Endo H deglycosylation resistant) 
and S2 (Endo H deglycosylation sensitive) that was inhibited by the furin or furin-like enzyme 
inhibitor, peptidyl chloromethylketone was also observed, confirming the bioinformatics prediction of 
the presence of cleavage site between S1 and S2 [6]. Using HCoV-HKU1 S pseudotyped virus, human 
alveolar epithelial A549 cells were shown to be the most susceptible cell line [4]. Using an A549 
cDNA expression library transduced into the non-permissive, baby hamster kidney cell line BHK-21 
for detecting proteins that bind HCoV-HKU1 S1-600 glycoprotein, independent clones with inserts 
encoding HLA-C were fished out. Further experiments also suggested that HLA-C is involved in the 
attachment of HCoV-HKU1 to A549 cells and is a potential candidate to facilitate cell entry [4]. 
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Table 1. Clinical studies on HCoV-HKU1. 
Studies Ref.  Place  of 
study 
No. of 
patients/ 
specimens 
Patient characteristics  Duration of 
study 
No. (%) of 
patients/ 
specimens 
positive for  
HCoV-
HKU1 
No. (%) of 
HCoV-
HKU1 
positive 
patients with 
underlying 
diseases 
No. (%) of patients/specimens positive 
for other human coronaviruses 
Outcome 
HCoV-
OC43 
HCoV-
229E 
HCoV-
NL63 
1 [42]  Hong  Kong  418 
patients 
Hospitalized patients 
with community-
acquired pneumonia 
12 months 
(Mar 2003 – 
Mar 2004) 
10 (2.4)  8 (80)  Not 
performed 
Not 
performed 
Not 
performed 
2 died 
2 [32]  Australia  324 
specimens 
Children presented to 
Queensland hospitals 
or general practitioners 
with acute respiratory 
tract infections 
4 months (May 
2004 – Aug 
2004) 
10 (3.1)  Not 
mentioned 
11 (3.4)  1 (0.3)  0 (0)  Not 
mentioned 
3 [35]  France 135 
patients 
Hospitalized patients 
with respiratory 
symptoms 
2 months (Feb 
2005 – Mar 
2005) 
6 (4.4)  3 (50)  2 (1.5)  0 (0)  2 (1.5)  Not 
mentioned 
4 [11]  USA  1048 
respiratory 
specimens 
from 851 
children 
Specimens from 
emergency department, 
inpatient wards, 
intensive care units, 
and hospital-affiliated 
primary care outpatient 
clinic 
12 months 
(Dec 2001 – 
Dec 2002) 
9 (1) 
patients 
5 (56)  Not 
performed 
Not 
performed 
Not 
performed 
Not 
mentioned 
5 [25]  Hong  Kong  4181 
specimens 
Hospitalized patients 
with acute respiratory 
tract infections 
12 months 
(April 2004 – 
Mar 2005) 
13 (0.3)  8 (62)  53 (1.3)  4 (0.1)  17 (0.4)  All 
survived 
6 [14]  Switzerland  540 
specimens 
from 279 
adults 
Hospitalized patients 
with respiratory disease 
20 months  4 (1.4) 
patients 
Not 
mentioned 
12 (4.3) 
patients 
7 (2.5) 
patients 
6 (2.2) 
patients 
Not 
mentioned 
7 [12]  Italy  2060 
children 
Children who attended 
the emergency 
department with an 
acute disease excluding 
trauma 
5 months (Nov 
2003 – Mar 
2004) 
0 (0)  -  17 (0.8)  42 (2)  20 (1)  - Viruses 2009, 1                                       
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Studies Ref.  Place  of 
study 
No. of 
patients/ 
specimens 
Patient characteristics  Duration of 
study 
No. (%) of 
patients/ 
specimens 
positive for  
HCoV-
HKU1 
No. (%) of 
HCoV-
HKU1 
positive 
patients with 
underlying 
diseases 
No. (%) of patients/specimens positive 
for other human coronaviruses 
Outcome 
HCoV-
OC43 
HCoV-
229E 
HCoV-
NL63 
8  [29] 
 
Italy 227 
children 
Hospitalized children 
with acute respiratory 
infection or related 
conditions at the 
Pediatric Department 
12 months 
(Oct 2004 – 
Sep 2005) 
0 (0)  -  6 (2.6)  0 (0)  1 (0.4)  - 
9 [15]  Italy  685 
specimens 
from  426 
patients 
Hospitalized patients 
with acute respiratory 
tract infections 
7 months (Nov 
2005 – May 
2006) 
10 (2.3) 
patients 
8 (80)  8 (1.9) 
patients 
20 (4.7) 
patients 
11 (2.6) 
patients 
Not 
mentioned 
10 [8]  Korea  231 
children 
Hospitalized children 
with acute expiratory 
wheezing 
10 months 
(Feb 2006 – 
Nov 2006) 
0 (0)  -  3 (1.3)  2 (0.9)  3 (1.3)  - 
11 [9]  Thailand  734 
patients 
 
1156 
patients 
 
513 
patients 
Patients hospitalized 
with pneumonia 
 
Patients  hospitalized 
with pneumonia 
 
Outpatients with 
influenza-like illness 
Study year 1: 
Sep 2003 – 
Aug 2004 
Study year 2: 
Sep 2004 – 
Oct 2005 
Study year 2: 
Sep 2004 – 
Oct 2005 
3 (0.4) 
 
 
9 (0.8) 
 
 
1 (0.2) 
Not 
mentioned 
31 (4.2) 
 
 
4 (0.4) 
 
 
0 (0) 
3 (0.4) 
 
 
7 (0.6) 
 
 
2 (0.4) 
7 (1) 
 
 
1 (0.1) 
 
 
9 (1.8) 
Not 
mentioned 
12 [21]  USA  1043 
children 
Outpatients, emergency 
department patients and 
inpatients with acute 
respiratory illness 
12 months 
(Oct 2003 – 
Sep 2004) 
28 (2.7)  Not 
mentioned 
19 (1.8)  8 (0.8)  11 (1.1)  Not 
mentioned Viruses 2009, 1                                       
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Studies Ref.  Place  of 
study 
No. of 
patients/ 
specimens 
Patient characteristics  Duration of 
study 
No. (%) of 
patients/ 
specimens 
positive for  
HCoV-
HKU1 
No. (%) of 
HCoV-
HKU1 
positive 
patients with 
underlying 
diseases 
No. (%) of patients/specimens positive 
for other human coronaviruses 
Outcome 
HCoV-
OC43 
HCoV-
229E 
HCoV-
NL63 
13  [30]  Switzerland  112 infants  Infants followed 
prospectively during 
their first year of life 
for any respiratory or 
other disease symptoms 
and their treatment by 
weekly telephone 
interviews 
69 months 
(Apr 1999 – 
Dec 2004) 
1 (0.9)  Not 
mentioned 
7 (6.3)  3 (2.7)  9 (8)  Not 
mentioned 
14 [36]  France  1002 
specimens 
from 928 
children 
Hospitalized children 
with respiratory or 
general symptoms 
9 months (Sep 
2004 – May 
2005) 
38 (3.8) 
specimens 
8 (24) of 34 
patients 
27 (2.9) 
specimens 
2 (0.2) 
specimens 
33 (3.6) 
specimens 
All 
survived 
15 [20]  Jordan  325 
children 
Children with acute 
respiratory infection 
admitted to the 
pediatric wards 
6 months (Dec 
2003 – May 
2004) 
0 (0)  -  Not 
performed 
Not 
performed 
4 (1.2)  - 
16  [3]  Italy  322 infants  Hospitalized infants 
with acute respiratory 
disease 
24 months  
(Oct 2004 – 
Sep 2006) 
6 (1.9)  Not 
mentioned 
11 (3.4)  1 (0.3)  10 (3.1)  Not 
mentioned 
17  [1]  Italy  85 infants  Infants hospitalized for 
the first acute episode 
of  wheezing 
6 months  
(Oct 2005 – 
Mar 2006) 
1 (1.2)  Not 
mentioned 
2 (2.4)  0 (0)  0 (0)  Not 
mentioned 
18 [13]  France  159 
specimens 
Specimens collected 
from mother-child 
couples admitted in 
labor to the 
Gynecology-Obstetrics 
Unit 
18 months (Jul 
2003 – Jun 
2004 and Mar 
2005 – Aug 
2005) 
1 (0.6)  Not 
mentioned 
0 (0)  11 (6.9)  0 (0)  Not 
mentioned Viruses 2009, 1                                       
 
 
65
3. Epidemiology 
In our studies on animal coronaviruses, no HCoV-HKU1 was detected in screening more than 
10,000 animal specimens in a variety of mammalian and avian species [23, 40, 41, 44]. The dn/ds 
ratios of all ORFs in the genomes of HCoV-HKU1 are low. Therefore, HCoV-HKU1 is stably 
evolving in humans, probably the only known reservoir. Similar to other respiratory viruses, HCoV-
HKU1 is presumably transmitted through exchange of respiratory secretions. The incidence of HCoV-
HKU1 infections is the highest in winter. Similar to other human coronaviruses, HCoV-HKU1 
infections have been reported globally (Table 1) [1,3,8,9,11-15,20,21,25,29,30,32,35,36,42]. From the 
studies with the incidence of all four human coronaviruses examined (Table 1), the median (range) 
incidence of HCoV-HKU1 was 0.9 (0 – 4.4) %, with no significant difference to those of HCoV-OC43 
[1.9 (0 – 6.3) %], HCoV-229E [0.4 (0 – 6.9) %] and HCoV-NL63 [1.1 (0 – 8.0) %]. Moreover, 
different human coronaviruses were more prevalent than the others in different studies.  
The seroprevalence of HCoV-HKU1 antibody varied widely in different studies that used different 
antigens and methodologies for antibody detection. In a recent study on seroepidemiology of HCoV-
HKU1 using Escherichia coli BL21 expressed recombinant S-based enzyme-linked immunosorbent 
assay (ELISA) and line immunoassay, it was observed that the seroprevalence of HCoV-HKU1 
antibody increased from 0% in patients who were <10 years old to a plateau of 22% in patients who 
were 31 to 40 years old [5]. In another study on seroepidemiology of the four human coronaviruses in 
Germany using E. coli BL21-expressed recombinant N-based line immunoassay, it was noted that the 
seropositivity for HCoV-HKU1 in 25 healthy blood donors was 48%, similar to those for HCoV-OC43 
(52%), HCoV-229E (56%) and HCoV-NL63 (60%) [26]. On the other hand, in another study of a US 
metropolitan population using baculovirus-expressed recombinant N-based ELISA, it was observed 
that the proportion of HCoV-HKU1 seropositive adults was 59.2%, significantly lower than those for 
HCoV-OC43 (90.8%), HCoV-229E (91.3%) and HCoV-NL63 (91.8%) [31]. Moreover, it was also 
observed that significantly different seropositivity rates for the various human coronaviruses were 
observed in individuals of different races, smoking status and socioeconomic status [31]. Further 
studies have to be performed to delineate whether these demographic factors confer differential risks 
of susceptibility to different human coronaviruses. 
 
4. Clinical diseases 
 
Similar to other human coronaviruses, HCoV-HKU1 is associated with both upper and lower 
respiratory tract infections. Respiratory tract infections associated with HCoV-HKU1 are 
indistinguishable from those associated with other respiratory viruses. For upper respiratory tract 
infections, most patients present with fever, running nose and cough; while for lower respiratory tract 
infections, fever, productive cough and dyspnea are common presenting symptoms. Most HCoV-
HKU1 infections are self-limiting, with only two deaths reported in patients with HCoV-HKU1 
pneumonia [42]. Both had underlying diabetes mellitus, cardiovascular diseases (myocardial infarction 
in one and cerebrovascular accident in the other) and cancers (gastric lymphoma in one and prostatic 
carcinoma in the other), lymphopenia and airspace shadows in both lungs [42]. Interestingly, a recent 
study from rural Thailand that involved control patients showed the presence of human coronaviruses Viruses 2009, 1                                       
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in >2% of control patients, which raised questions about the role of human coronaviruses in 
pneumonia [9]. At the moment, no antiviral drugs or vaccines for HCoV-HKU1 and the other human 
coronaviruses are available. Symptomatic and supportive treatment is the mainstay of therapy given to 
patients suffering from infections caused by these viruses.  
In addition to respiratory tract infections, HCoV-HKU1 has been found in other illnesses. In our 
one-year prospective study, it was observed that HCoV-HKU1 infection was associated with febrile 
seizures [25]. On the other hand, in another French study, although six (17.6%) of the 34 HCoV-
HKU1 infected children were admitted for epileptic seizures, HCoV-HKU1 infections were not shown 
to be associated with febrile seizures [36]. In one study, HCoV-HKU1 was detected in the stool 
samples of two patients with respiratory tract infections but no gastrointestinal tract symptoms, but it 
was not detected in patients with diarrhea [35]. In another study, HCoV-HKU1 was detected in a liver 
transplant recipient with hepatitis, which other causes of hepatitis, such as graft rejection, 
cytomegalovirus, etc. were excluded [11]. The significance of HCoV-HKU1 febrile seizures, 
gastroenteritis and hepatitis remains to be determined. 
5. Laboratory diagnosis 
The most common method for making a diagnosis of HCoV-HKU1 infection is RT-PCR or real-
time RT-PCR using RNA extracted from respiratory tract samples such as nasopharyngeal aspirates 
(NPA). Both the pol and N genes have been used as the targets for amplification (Table 2). In our 
index patient, the viral loads in the NPA of the patient were 10
6 to 10
7 and 10
5 copies/ml of NPA in the 
first and second weeks of illness respectively, and became undetectable from the third week of illness 
onwards [39]. Recently, DNA microarrays have also been used for detection of HCoV-HKU1 and 
other human coronaviruses, and the sensitivity was found to be similar to that of individual real-time 
RT-PCR [10]. In addition to nucleic acid detection, monoclonal antibodies have been generated for 
direct antigen detection in NPA, although the targets for the binding of the monoclonal antibodies are 
still not known [15].  
For antibody detection, E. coli BL21- and baculovirus-expressed recombinant N of HCoV-HKU1 
has been used for IgG and IgM detection in sera of patients and normal individuals, using Western blot 
and ELISA [5,26,31,39,42]. In our index patient, his serum IgG titer rose from <1:1,000 in the first 
week of his illness to 1:2,000 and 1:8,000 in the second and fourth weeks of his illness respectively, 
whereas the IgM titers in the first, second and fourth weeks were 1:20, 1:40, and 1:80 respectively 
[39]. Furthermore, in our retrospective study of patients with community acquired pneumonia, all the 
six patients with serum samples available showed four-fold changes in IgG titer and/or presence of 
IgM against HCoV-HKU1 [42]. Although HCoV-HKU1 is still not cultivable, a neutralization 
antibody test was also developed recently using HCoV-HKU1 pseudotyped virus [5]. 
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Table 2.  Gene targets and primer sequences for HCoV-HKU1 detection 
Studies References Place  of 
study 
Detection 
methods 
Gene 
target 
Target 
band size 
Primer sequences 
1 [42]  Hong  Kong  RT-PCR  pol  453 bp  Forward 5’-AAAGGATGTTGACAACCCTGTT-3’ 
Reverse 5’-ATCATCATACTAAAATGCTTACA-3’ 
2 [32]  Australia  RT-PCR  pol 453  bp  Forward 5’-AAAGGATGTTGACAACCCTGTT-3’ 
Reverse 5’-ATCATCATACTAAAATGCTTACA-3’ 
3  [35]  France  RT-PCR  N  443 bp  
 
Forward 5’-ACCAATCTGAGCGAAATTACCAAAC-3’ 
Reverse 5’-CGGAAACCTAGTAGGGATAGCTT-3’ 
4 [11]  USA  RT-PCR  pol  440 bp  Forward 5’-GGTTGGGATTATCCTAAATGTGA-3’ 
Reverse 5’-CCATCATCACTCAAAATCATCATA-3’ 
5 [25]  Hong  Kong  RT-PCR  pol 453  bp  Forward 5’-AAAGGATGTTGACAACCCTGTT-3’ 
Reverse 5’-ATCATCATACTAAAATGCTTACA-3’ 
6 [14]  Switzerland  Real-time   
RT-PCR 
pol  506 bp  Forward 5’-GAATTTTGTTGTTCACATGGTGATAGA-3’ 
Reverse 5’-GCAACCGCCACACATAACTATTT-3’ 
Probe 5’-FAM-TTTATCGCCTTGCGAATGAATGTGCTC-
TAMRA-3’ 
7 [12]  Italy  Real-time   
RT-PCR 
N  64 bp  Forward 5’-AGTTCCCATTGCTTTCGGAGTA-3’ 
Reverse 5’-CCGGCTGTGTCTATACCAATATCC-3’ 
Probe 5’-FAM-CCCCTTCTGAAGCAA-MGB-3’ 
8  [29] 
 
Italy RT-PCR  pol  440 bp  Forward 5’-GGTTGGGACTATCCTAAGTGTGA-3’ 
Reverse 5’-CCATCATCAGATAGAATCATCATA-3’ 
9 [15]  Italy  RT-PCR  N 
 
pol 
516 bp 
 
250 bp 
Forward 5’-CAGTGTTTTGGTAAAAGAGGACC-3’ 
Reverse 5’-TACCACCTAGTGTCGAATTAGG-3’ 
Forward 5’-ACTCAAATGAATTTAAAATATGC-3’ 
Reverse 5’-TCACATTTAGGATAATCCCA-3’ 
10 [8]  Korea  RT-PCR  pol  
 
pol  
 
pol  
 
921 bp 
 
989 bp 
 
921 bp 
Forward 5’-GTTCAAGTGTCGCTGTTCA-3’ 
Reverse 5’-CTATCATTATCACAATCCACAG-3’ 
Forward 5’-GGGTATGAAGTATCATCCTA-3’ 
Reverse 5’-GATAATCCCAACCCATAAGAAC-3’ 
Forward 5’-CATCTTATAAAGGATGTTGAC-3’ 
Reverse 5’-ACAAACAACACATGCACCTACAC-3’ 
11 [9]  Thailand  Real-time   
RT-PCR 
pol  
 
95 bp  Forward 5’-CCTTGCGAATGAATGTGCT-3’ 
Reverse 5’-TTGCATCACCACTGCTAGTACCAC-3’ 
Probe 5’-FAM-TGTGTGGCGGTTGCTATTATGTTAAGCCTG
Black Hole Quencher–1-3’ 
12 [21]  USA  Real-time   
RT-PCR 
pol  
 
96 bp  Forward 5’-TGGTGGCTGGGACGATATGT-3’ 
Reverse 5’-GGCATAGCACGATCACACTTAGG-3’ 
Probe 5’-6FAM-ATAATCCCAACCCATRAG-Quencher -3’ 
13 [30]  Switzerland  Real-time   
RT-PCR 
pol  
 
506 bp  Forward 5’-GAATTTTGTTGTTCACATGGTGATAGA-3’ 
Reverse 5’-GCAACCGCCACACATAACTATTT-3’ 
Probe 5’-FAM-TTTATCGCCTTGCGAATGAATGTGCTC-
TAMRA-3’ 
14  [36]  France  RT-PCR  N  439 bp   Forward 5’-ATCTGARCGAAAYYAYCAAAC-3’ 
Reverse 5’-CGYAAACCTAGTAGGGATAGCTT-3’ 
15 [20]  Jordan  RT-PCR  pol  
 
453 bp  Forward 5’-AAAGGATGTTGACAACCCTGTT-3’ 
Reverse 5’-ATCATCATACTAAAATGCTTACA-3’ 
16 [3]  Italy  RT-PCR  pol  
 
pol  
 
220bp 
 
214bp 
Forward 5’-TTATGGGTTGGGATTATCCYAARTGTGAT-3’ 
Reverse 5’-GTACTAGCRTCACCAGAAGTYGTACCACC-3’ 
Forward2 5’-
ATGGGATGGGACTATCCTAAGTGTGATAGAG-3’ 
Reverse2 5’-TTGCATCACCACTRCTAGTRCCACCAGGC-3’ 
17 [1]  Italy  RT-PCR  pol  
 
440 bp  Forward 5’-GGTTGGGACTATCCTAAGTGTGA-3’ 
Reverse 5’-CCATCATCAGATAGAATCATCATA-3’ 
18 [13]  France Real-time   
RT-PCR 
pol  
 
96 bp  Forward 5’-TGGTGGCTGGGACGATATGT-3’ 
Reverse 5’-GGCATAGCACGATCACACTTAGG-3’ 
Probe 5’-6FAM-ATAATCCCAACCCATRAG-Quencher -3’ Viruses 2009, 1                                       
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6. Concluding remarks 
The discovery of SARS coronavirus marked the beginning of the race of coronavirus hunting in 
humans and animals. In just a few years, the number of “coronavirus” papers found by Medline search 
has doubled and the number of coronaviruses with complete genomes available has tripled. With this 
increase in the number of coronaviruses and genomes, we are starting to appreciate the diversity of 
coronaviruses. Moreover, comprehensive and user-friendly databases for efficient sequence retrieval 
and the ever-improving bioinformatics tools have further enabled us to improve our understanding of 
the phylogeny and genomics of coronaviruses [19]. With the increasing number of coronaviruses, 
more and more closely related coronaviruses from distantly related animals have been observed. The 
most notable example related to human coronaviruses is the clustering of HCoV-OC43, bovine 
coronavirus and porcine hemagglutinating encephalomyelitis virus. With more and more coronaviruses 
discovered, we will be able to understand the origin of the various human coronaviruses, and more 
importantly, the secret behind their mechanisms of interspecies transmission. 
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